Sökresultat

Filtyp

Din sökning på "swedish" gav 95906 sökträffar

Protokoll-bilagor-us-191023

Bästa resultat får du om du öppnar den här PDF-portföljen i Acrobat X eller Adobe Reader X eller senare. Hämta Adobe Reader nu! http://www.adobe.com/go/reader_download_se Postadress Box 117, 221 00 Lund Besöksadress Wrangel, Biskopsgatan 5 Telefon 046-222 94 35, 046-222 00 00, 0722-31 71 64 E-post anna.akesson@rektor.lu.se Univers i te tss tyre lsen Årsplan för universitetsstyrelsen 2020 Fastställ

https://www.lu.se/sites/www.lu.se/files/protokoll-bilagor-us-191023.pdf - 2026-05-15

Protokoll-bilagor-us150612

Bästa resultat får du om du öppnar den här PDF-portföljen i Acrobat X eller Adobe Reader X eller senare. Hämta Adobe Reader nu! http://www.adobe.com/go/reader_download_se Rektor Riskvärdering för Lunds universitet Enligt förordningen om intern styrning och kontroll (SFS 2007:603) ska universitetet göra en riskanalys i syfte att identifiera omständigheter som utgör risk för att de krav som framgår

https://www.lu.se/sites/www.lu.se/files/protokoll-bilagor-us150612.pdf - 2026-05-15

Framtidens-fysiska-butik-webb

258446_Ulf Johansson Framtidens fysiska butik Digitalisering, upplevelser och hållbarhet ULF JOHANSSON (RED.) CENTRUM FÖR HANDELSFORSKNING | LUNDS UNIVERSITET Handelsrådet Centrum för handelsforskning vid Lunds universitet ISBN 978-91-86508-55-5 Framtidens fysiska butik – digitalisering, upplevelser och hållbarhet Handeln befinner sig i en tid av förändring. I decennier har handeln arbetat på samm

https://www.lusem.lu.se/sites/lusem.lu.se/files/2024-01/framtidens-fysiska-butik-webb.pdf - 2026-05-15

"Equality Data Vital to Assess and Combat Discrimination" - The Raoul Wallenberg Institute of Human

"Equality Data Vital to Assess and Combat Discrimination" - The Raoul Wallenberg Institute of Human Rights and Humanitarian Law Skip to content Search for: Search Button Home About Us Who We Are Our History About Raoul Wallenberg Our Theory of Change Staff Opportunities Annual Reports Whistleblower Our work What we do Multi-Disciplinary Research Higher Education Strategic Advice and Analysis Outre

https://rwi.lu.se/2017/01/04/equality-data-vital-assess-combat-discrimination/ - 2026-05-14

Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based study.

The inflammatory mediator procalcitonin (PCT) has previously been associated with prognosis in myocardial infarction, cancer and sepsis patients. The importance of PCT in the general population is currently unknown. Our aim was to assess the relationship between plasma PCT and the risk of all-cause and cause-specific mortality in apparently healthy individuals with no previous history of cardiovas

Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?

In a previously published study, vildagliptin showed a reduced risk of hypoglycemia versus glimepiride as add-on therapy to metformin at similar efficacy. Glimepiride was titrated from a starting dose of 2 mg/day to a maximum dose of 6 mg/day. It is usually assumed that the increased hypoglycemia with glimepiride was driven by the 6 mg/day dose; it was therefore of interest to assess whether the r

Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy.

Epigenetic variation has been linked to several human diseases. Proliferative diabetic retinopathy (PDR) is a major cause of vision loss in subjects with diabetes. However, studies examining the association between PDR and the genome-wide DNA methylation pattern are lacking. Our aim was to identify epigenetic modifications that associate with and predict PDR in subjects with type 1 diabetes (T1D).

SAFE MULTIBYGG AP 1-4 : Delrapport

Multifunctional buildings are characterized by multiple functions located within the same building. In this report specific problem areas are identified by the means of interviews and previous method development. The risks identified consider multifunctionality and antagonistic attacks. As a result from the previous method developed and the interviews, reference scenarios are suggested and conclus

Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.

Most acute cardiovascular events are caused by rupture of an atherosclerotic plaque. The incidence of cardiovascular events increases with age and inflammation is generally considered to be the main cause of increased plaque vulnerability. However, the relationship between age and plaque inflammation has not yet been fully clarified. The aim of our study was to determine if age-dependent plaque vu

Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men.

Salt-induced elevation of the endogenous digitalis like sodium pump ligand marinobufagenin (MBG) in the Dahl salt-sensitive rats resulted in elevated blood pressure (BP). Here, we tested, in humans, whether MBG levels are related to ambulatory 24-h BP (ABP), controlled long-term increase of salt-intake induces changes in MBG and any salt-induced change in MBG is related to salt sensitivity.

Twelve-Single Nucleotide Polymorphism Genetic Risk Score Identifies Individuals at Increased Risk for Future Atrial Fibrillation and Stroke.

Atrial fibrillation (AF) is prevalent and there is a clinical need for biomarkers to identify individuals at higher risk for AF. Fixed throughout a life course and assayable early in life, genetic biomarkers may meet this need. Here, we investigate whether multiple single nucleotide polymorphisms together as an AF genetic risk score (AF-GRS) can improve prediction of one's risk for AF.

NIH working group report-using genomic information to guide weight management: From universal to precision treatment.

Precision medicine utilizes genomic and other data to optimize and personalize treatment. Although more than 2,500 genetic tests are currently available, largely for extreme and/or rare phenotypes, the question remains whether this approach can be used for the treatment of common, complex conditions like obesity, inflammation, and insulin resistance, which underlie a host of metabolic diseases.